Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes
Abstract
Objectives
Dual antiplatelet therapy (DAPT) with aspirin + a P2Y12 inhibitor is recommended for at least 12 months for patients with acute coronary syndrome (ACS), with shorter durations considered for patients with increased bleeding risk. However, there are no decision support tools available to predict an individual patient’s bleeding risk during DAPT treatment in the post-ACS setting.Methods
To develop a longitudinal...Paper Details
Title
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes
Published Date
Apr 5, 2017
Journal
Volume
103
Issue
15
Pages
1168 - 1176
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History